Product Information
VARENICLINE 1 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3161 per EA under NDC 70748012849. Its NADAC has been published 141 times since Jan 24, 2024.
FDA first approved this application on Dec 4, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748012849
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VARENICLINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211862FDA Approved
12/4/2023
TE Code
AB
On Market Since
1/9/2024
Pharmacological Classes
Price Statistics
The NADAC for VARENICLINE 1 MG TABLET has been published 141 times since Jan 24, 2024, and over the history we have for it it has declined 86.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3161 per EA |
|---|---|
| All-time high | $2.3627 (Apr 10, 2024) |
| All-time low | $0.3161 (Sep 23, 2026) |
| 52-week high | $0.4838 |
| 52-week low | $0.3161 |
| Median price | $0.5408 |
| Average price | $0.7971 |
| Largest weekly change | -51.0% (Nov 20, 2024) |
| Weeks tracked | 141 |
| Tracking since | Jan 24, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VARENICLINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARENICLINE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 1 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3161 per EA (NDC 70748012849), effective Sep 30, 2026.
How has the price of VARENICLINE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for VARENICLINE 1 MG TABLET has declined 86.4%. It has been tracked across 141 weekly CMS publications since Jan 24, 2024.
What are the highest and lowest recorded NADAC prices for VARENICLINE 1 MG TABLET?
Since Jan 24, 2024, the NADAC for VARENICLINE 1 MG TABLET has ranged from a low of $0.3161 (Sep 23, 2026) to a high of $2.3627 (Apr 10, 2024), with a median of $0.5408 per EA.
Are there cheaper alternatives to VARENICLINE 1 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VARENICLINE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VARENICLINE 1 MG TABLET?
VARENICLINE 1 MG TABLET (NDC 70748012849) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.